Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: Pathogenetic implications and clinical correlations.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Blood

• Publication date

  2006-09-19

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD-2006-03-012948PMID 16985177
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Strikingly homologous immunoglobulin gene rearrangements and poor outcome in VH3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status.

  2005cited by this paper
• Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene.

  2005cited by this paper
• Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity

  2005cited by this paper
• Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity.

  2005cited by this paper
• IMGT standardized criteria for statistical analysis of immunoglobulin V‐REGION amino acid properties

  2004cited by this paper
• Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins.

  2004cited by this paper
• Multiple Distinct Sets of Stereotyped Antigen Receptors Indicate a Role for Antigen in Promoting Chronic Lymphocytic Leukemia

  2004cited by this paper
• Immunoglobulin light chain repertoire in chronic lymphocytic leukemia.

  2004cited by this paper
• IMGT, the international ImMunoGeneTics information system®

  2004cited by this paper
• Chronic lymphocytic leukemia : revelations from the B-cell receptor

  2004cited by this paper
• IMGT/JunctionAnalysis: the first tool for the analysis of the immunoglobulin and T cell receptor complex V-J and V-D-J JUNCTIONs

  2004cited by this paper
• Subsets with restricted immunoglobulin gene rearrangement features indicate a role for antigen selection in the development of chronic lymphocytic leukemia.

  2004cited by this paper
• Immunoglobulin Heavy- And Light-chain Repertoire in Splenic Marginal Zone Lymphoma

  2004cited by this paper
• Revisiting the definition of somatic mutational status in B-cell tumors: does 98% homology mean that a VH-gene is unmutated?

  2004cited by this paper
• Chronic lymphocytic leukemia: revelations from the B-cell receptor.

  2004cited by this paper
• Remarkably similar antigen receptors among a subset of patients with chronic lymphocytic leukemia.

  2004cited by this paper
• IMGT®, the international ImMunoGeneTics information system®

  2004cited by this paper
• von Willebrand factor cleavage ADAMTS-13 cysteine-rich / spacer domains are functionally essential for

  2003cited by this paper
• Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations.

  2003cited by this paper
• Memory B cells producing somatically mutated antiphospholipid antibodies are present in healthy individuals.

  2003cited by this paper
• Positive Selection of Anti–Thy-1 Autoreactive B-1 Cells and Natural Serum Autoantibody Production Independent from Bone Marrow B Cell Development

  2003cited by this paper
• Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia.

  2003cited by this paper
• Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope.

  2003cited by this paper
• Predominant Autoantibody Production by Early Human B Cell Precursors

  2003cited by this paper
• High frequency of p53 dysfunction and low level of VH mutation in chronic lymphocytic leukemia patients using the VH3-21 gene segment.

  2003cited by this paper
• IMGT - the international ImMunoGeneTics information system

  2003cited by this paper
• Anti-DNA antibodies: aspects of structure and pathogenicity

  2003cited by this paper
• B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor.

  2003cited by this paper
• Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936

  2003cited by this paper
• Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia.

  2002cited by this paper
• Analysis of the IgV(H) somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course.

  2002cited by this paper
• lymphocytic leukemia ( CLL ) patients at risk of disease progression

  2002cited by this paper
• Peritoneal CD5+ B-1 Cells Have Signaling Properties Similar to Tolerant B Cells*

  2002cited by this paper
• Systematic analysis of sequences of anti-DNA antibodies—relevance to theories of origin and pathogenicity

  2002cited by this paper
• A model B-cell superantigen and the immunobiology of B lymphocytes.

  2002cited by this paper
• Chronic B cell malignancies and bone marrow microenvironment.

  2002cited by this paper
• Autoreactivity by design: innate B and T lymphocytes

  2001cited by this paper
• Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma.

  2001cited by this paper
• Normal B Cells Express 51p1-Encoded Ig Heavy Chains That Are Distinct From Those Expressed by Chronic Lymphocytic Leukemia B Cells1

  2001cited by this paper
• Regulation of inherently autoreactive VH4-34 B cells in the maintenance of human B cell tolerance.

  2001cited by this paper
• The occurrence and significance of V gene mutations in B cell-derived human malignancy.

  2001cited by this paper
• Editors and editing of anti-DNA receptors.

  2001cited by this paper
• Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas.

  2000cited by this paper
• Salivary gland mucosa-associated lymphoid tissue lymphoma immunoglobulin V(H) genes show frequent use of V1-69 with distinctive CDR3 features.

  2000influential reference
• Molecular insights into the immunopathogenesis of follicular lymphoma.

  2000cited by this paper
• Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia.

  2000cited by this paper
• Structure‐function analysis of a lupus anti‐DNA autoantibody: central role of the heavy chain complementarity‐determining region 3 Arg in binding of double‐ and single‐stranded DNA

  2000cited by this paper
• Cd5 Maintains Tolerance in Anergic B Cells

  2000cited by this paper
• Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

  1999cited by this paper
• Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.

  1999cited by this paper
• V(H) gene sequences from primary central nervous system lymphomas indicate derivation from highly mutated germinal center B cells with ongoing mutational activity.

  1999cited by this paper
• Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment.

  1999influential reference
• Analysis of heavy and light chain pairings indicates that receptor editing shapes the human antibody repertoire.

  1999cited by this paper
• Two human neonatal IgM antibodies encoded by different variable-region genes bind the same linear peptide: evidence for a stereotyped repertoire of epitope recognition.

  1999cited by this paper
• Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors.

  1998cited by this paper
• Analysis of VH genes in follicular and diffuse lymphoma shows ongoing somatic mutation and multiple isotype transcripts in early disease with changes during disease progression.

  1998cited by this paper
• Pairing of variable heavy and variable kappa chains in individual naive and memory B cells.

  1998cited by this paper
• Preferential IgH V4-34 gene segment usage in particular subtypes of B-cell lymphoma detected by antibody 9G4.

  1998influential reference
• VH gene analysis of primary cutaneous B-cell lymphomas: evidence for ongoing somatic hypermutation and isotype switching.

  1998cited by this paper
• Lack of Allelic Exclusion in B Cell Chronic Lymphocytic Leukemia

  1997cited by this paper
• Myeloma VL and VH gene sequences reveal a complementary imprint of antigen selection in tumor cells.

  1997cited by this paper
• Diffuse large cell lymphomas are derived from mature B cells carrying V region genes with a high load of somatic mutation and evidence of selection for antibody expression

  1997cited by this paper
• Differences in mutational patterns between rheumatoid factors in health and disease are related to variable heavy chain family and germ‐line gene usage

  1997cited by this paper
• Ongoing Ig gene hypermutation in salivary gland mucosa-associated lymphoid tissue-type lymphomas.

  1997cited by this paper
• Evolution of the structural repertoire of the human V(H) and Vkappa germline genes.

  1997cited by this paper
• Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features.

  1997cited by this paper
• VH gene usage is multiple myeloma: complete absence of the VH4.21 (VH4-34) gene.

  1996influential reference
• The V4-34 encoded anti-i autoantibodies recognize a large subset of human and mouse B-cells.

  1996cited by this paper
• Correlation between the amino acid position of arginine in VH-CDR3 and specificity for native DNA among autoimmune antibodies.

  1996cited by this paper
• National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment.

  1996cited by this paper
• CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis.

  1996cited by this paper
• Human autoantibody recognition of DNA.

  1995cited by this paper
• Connection between Immunosuppressants and Steroids via HSP90

  1995cited by this paper
• Crystal Structure of a Cross-reaction Complex between Fab F9.13.7 and Guinea Fowl Lysozyme (*)

  1995cited by this paper
• Polymorphism and Utilization of Human VH Genes a

  1995cited by this paper
• In vitro assembly of repertoires of antibody chains on the surface of phage by renaturation.

  1994cited by this paper
• V gene usage by seven hybrids derived from CD5+ B-cell chronic lymphocytic leukemia and displaying autoantibody activity

  1993cited by this paper
• V gene usage by seven hybrids derived from CD5+ B-cell chronic lymphocytic leukemia and displaying autoantibody activity.

  1993cited by this paper
• The structural basis of germline-encoded VH3 immunoglobulin binding to staphylococcal protein A

  1993cited by this paper
• High-affinity self-reactive human antibodies by design and selection: targeting the integrin ligand binding site.

  1993cited by this paper
• Residues that mediate DNA binding of autoimmune antibodies.

  1993cited by this paper
• Structural repertoire of the human VH segments.

  1992cited by this paper
• Evidence that chronic lymphocytic leukemia B lymphocytes are frequently committed to production of natural autoantibodies.

  1990cited by this paper
• Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia

  1989cited by this paper
• Autoantibody-associated cross-reactive idiotypes expressed at high frequency in chronic lymphocytic leukemia relative to B-cell lymphomas of follicular center cell origin.

  1988cited by this paper
• Autoantibody-associated kappa light chain variable region gene expressed in chronic lymphocytic leukemia with little or no somatic mutation. Implications for etiology and immunotherapy

  1988cited by this paper
• Sequence-specific recognition of double helical nucleic acids by proteins.

  1976cited by this paper

• Molecular Mechanisms in the Transformation from Indolent to Aggressive B Cell Malignancies

  2025cites this paper
• Insights into the pathogenesis and biology of chronic lymphocytic leukemia through analysis of its B-cell receptor

  2025cites this paper
• IGLV 3-21R110-directed bispecific antibodies activate T cells and promote killing in a high-risk subset of chronic lymphocytic leukemia

  2025cites this paper
• Autonomous B-cell Receptor Signaling in Chronic Lymphocytic Leukemia.

  2025cites this paper
• Performance of Rapid Clonotyping of Chronic Lymphocytic Leukemia Using Flongle Flow‐Cell Nanopore Sequencing of IGH Rearrangements

  2025cites this paper
• Recombinant Production of B-Cell Receptor Fab Fragments from Chronic Lymphocytic Leukemia in Mammalian Cells for Structural and Biochemical Studies.

  2025cites this paper
• Defective cell-autonomous signalling and antigenic polyreactivity of B-cell receptors from chronic lymphocytic leukaemia stereotyped subset 1

  2025influential citation
• Disease-specific U1 spliceosomal RNA mutations in mature B-cell neoplasms

  2025cites this paper
• Stereotyped B-Cell Receptor Immunoglobulins in B-Cell Lymphomas.

  2025cites this paper
• Autoimmunity promotes chronic lymphocytic leukemia progression in an indolent disease model

  2025cites this paper
• Measurable/Minimal Residual Disease: What Method and What Cut-Off?

  2025cites this paper
• CLL‐like stereotyped BCRs are equally produced in young and old healthy adults, share features of public clonotypes and may be stuck at a pre‐germinal centre stage

  2025cites this paper
• Conventional and non-conventional antigen-binding sites promote the development and function of chronic lymphocytic leukemia stereotyped subset #4 clones

  2025cites this paper
• Analysis of Stereotyped B-Cell Receptor Frequencies Among Portuguese De Novo-Diagnosed Chronic Lymphocytic Leukemia Patients (PAIS Study)

  2025cites this paper
• Mutation-specific CAR T cells as precision therapy for IGLV3-21R110 expressing high-risk chronic lymphocytic leukemia

  2024cites this paper
• Case report: ‘Atypical Richter transformation from CLL-type monoclonal B-cell lymphocytosis into Burkitt lymphoma in a treatment naïve patient’

  2024cites this paper
• Persistent B-Cell Stimulation or B-Cell Repertoire Anomalies? The Dilemma of the Origin of CLL

  2024cites this paper
• SOHO State of the Art Updates and Next Questions | Impact of Biologic Markers on Outcomes With Novel Therapy in Chronic Lymphocytic Leukaemia.

  2024cites this paper
• Risk scores predicting disease progression in early‐stage chronic lymphocytic leukemia: Comparative analysis and usefulness of IGHV subset #2 to improve their accuracy

  2024cites this paper
• EXPRESSION OF IMMUNOGLOBULIN LIGHT CHAIN GENES IN STEREOTYPED CASES FROM UKRAINIAN COHORT OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS.

  2024cites this paper
• An overview of prognostic markers in patients with CLL

  2024cites this paper
• Immunoglobulin light chain mutational status refines IGHV prognostic value in identifying chronic lymphocytic leukemia patients with early treatment requirement

  2024cites this paper
• Social deprivation independently impacts clinical outcomes in patients with chronic lymphocytic leukemia

  2024cites this paper
• Consensus guidelines for the management of treatment-naïve chronic lymphocytic leukaemia in Singapore (2024).

  2024cites this paper
• CD20+ T cells in monoclonal B cell lymphocytosis and chronic lymphocytic leukemia: frequency, phenotype and association with disease progression

  2024cites this paper
• The VLA-4 integrin is constitutively active in circulating chronic lymphocytic leukemia cells via BCR autonomous signaling: a novel anchor-independent mechanism exploiting soluble blood-borne ligands

  2024cites this paper
• Should We Note Subset #2-Positive Patients as a Specific Group Within Mutated or Unmutated CLL?

  2024cites this paper
• Immunological Aspects of Richter Syndrome: From Immune Dysfunction to Immunotherapy

  2023cites this paper
• Characterization of clonal immunoglobulin heavy V-D-J gene rearrangements in Chinese patients with chronic lymphocytic leukemia: Clinical features and molecular profiles

  2023cites this paper
• Patient specific real-time PCR in precision medicine – Validation of IG/TR based MRD assessment in lymphoid leukemia

  2023cites this paper
• Clonal Characterization and Somatic Hypermutation (SHM) Assessment by Next Generation Sequencing in Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma (CLL/SLL): A Detailed Description of the Technical Performance, Clinical Utility, and Platform Comparison.

  2023cites this paper
• Autonomous B-cell receptor signaling and genetic aberrations in chronic lymphocytic leukemia-phenotype monoclonal B lymphocytosis in siblings of patients with chronic lymphocytic leukemia

  2023cites this paper
• N-Glycosylation of the Ig Receptors Shapes the Antigen Reactivity in Chronic Lymphocytic Leukemia Subset #201.

  2023cites this paper
• Mutation-specific CAR T cells as precision therapy for IGLV3-21R110 expressing high-risk chronic lymphocytic leukemia

  2023cites this paper
• Concurrent development of small lymphocytic lymphoma and lung cancer: A report of two cases and a review of the literature

  2023cites this paper
• The inhibitory receptor Siglec‐G controls the severity of chronic lymphocytic leukemia

  2023cites this paper
• Application of germline antibody features to vaccine development, antibody discovery, antibody optimization and disease diagnosis.

  2023cites this paper
• Diagnosis and Molecular Pathology of Lymphoblastic Leukemias and Lymphomas in the Era of Genomics and Precision Medicine: Historical Evolution and Current Concepts—Part 3: Mature Leukemias/Lymphomas

  2023cites this paper
• Differences in the immunoglobulin gene repertoires of IgG versus IgA multiple myeloma allude to distinct immunopathogenetic trajectories

  2023cites this paper
• B cell receptor immunoglobulin stereotypy in chronic lymphocytic leukemia: Key to understanding disease biology and stratifying patients.

  2023cites this paper
• CLL update 2022: A continuing evolution in care.

  2022cites this paper
• IMGT® Homo sapiens IG and TR Loci, Gene Order, CNV and Haplotypes: New Concepts as a Paradigm for Jawed Vertebrates Genome Assemblies

  2022cites this paper
• Overexpression of wild type RRAS2, without oncogenic mutations, drives chronic lymphocytic leukemia

  2022cites this paper
• Richter Syndrome: From Molecular Pathogenesis to Druggable Targets

  2022cites this paper
• Old and New Facts and Speculations on the Role of the B Cell Receptor in the Origin of Chronic Lymphocytic Leukemia

  2022cites this paper
• Evidence of somatic hypermutation in the antigen binding sites of patients with CLL harboring IGHV genes with 100% germline identity

  2022cites this paper
• 5' Rapid amplification of cDNA ends (5'RACE): A simpler method to analyze immunoglobulin genes and discover the value of the light chain in chronic lymphocytic leukemia.

  2022cites this paper
• EXABS-176-CLL Clinical Significance of B-Cell Receptor Stereotype in CLL.

  2022cites this paper
• Distinct Immunogenetic Profiles of Chronic Lymphocytic Leukemia in Asia: A Taiwan Cooperative Oncology Group Registry Study

  2022cites this paper
• Genomic Profiling for Clinical Decision Making in Lymphoid Neoplasms.

  2022cites this paper
• Immune receptor CDR3 chemical features that preserve sequence information are highly efficient in reflecting survival distinctions: A pan-cancer analysis.

  2022cites this paper
• A case report of pre-eclampsia-like endothelial injury in the kidney of an 85-year-old man treated with ibrutinib

  2022cites this paper
• Next-generation sequencing for MRD monitoring in B-lineage malignancies: from bench to bedside

  2022cites this paper
• Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: the 2022 update of the recommendations by ERIC, the European Research Initiative on CLL

  2022cites this paper
• The enigmatic cell of origin of chronic lymphocytic leukemia

  2022cites this paper
• Brief Report

  2021cites this paper
• The Hydropathy Index of the HCDR3 Region of the B-Cell Receptor Identifies Two Subgroups of IGHV-Mutated Chronic Lymphocytic Leukemia Patients With Distinct Outcome

  2021cites this paper
• Distinctive Signaling Profiles With Distinct Biological and Clinical Implications in Aggressive CLL Subsets With Stereotyped B-Cell Receptor Immunoglobulin

  2021cites this paper
• Understanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors

  2021cites this paper
• Brief Report

  2021cites this paper
• Perspectives on Precision Medicine in Chronic Lymphocytic Leukemia: Targeting Recurrent Mutations—NOTCH1, SF3B1, MYD88, BIRC3

  2021cites this paper
• Potential Relevance of B-cell Maturation Pathways in Defining the Cell(s) of Origin for Chronic Lymphocytic Leukemia.

  2021cites this paper
• Az IGHV-mutációs státusz vizsgálata a Magyar Hematológiai és Transzfuziológiai Társaság Molekuláris Diagnosztika Munkacsoportjának laboratóriumaiban

  2021cites this paper
• Developmental partitioning of SYK and ZAP70 prevents autoimmunity and cancer.

  2021cites this paper
• A 3′ tRNA‐derived fragment produced by tRNALeuAAG and tRNALeuTAG is associated with poor prognosis in B‐cell chronic lymphocytic leukemia, independently of classical prognostic factors

  2021cites this paper
• T Cells in Chronic Lymphocytic Leukemia: A Two-Edged Sword

  2021cites this paper
• TCR+/BCR+ dual-expressing cells and their associated public BCR clonotype are not enriched in type 1 diabetes.

  2021cites this paper
• A multi-objective based clustering for inferring BCR clones from high-throughput B cell repertoire data

  2021cites this paper
• Incorporating molecular biomarkers into the continuum of care in chronic lymphocytic leukemia

  2021cites this paper
• The Significance of B-cell Receptor Stereotypy in Chronic Lymphocytic Leukemia: Biological and Clinical Implications.

  2021cites this paper
• Proteomic analysis of plasma exosomes in patients with non-small cell lung cancer

  2021cites this paper
• Immune Gene Rearrangements: Unique Signatures for Tracing Physiological Lymphocytes and Leukemic Cells

  2021cites this paper
• 二代测序检测多发性骨髓瘤IGH基因克隆性重排临床价值

  2021cites this paper
• Longitudinal analyses of CLL in mice identify leukemia-related clonal changes including a Myc gain predicting poor outcome in patients

  2021cites this paper
• HSP90 overexpression potentiates the B-cell receptor and fibroblast growth factor receptor survival signals in chronic lymphocytic leukemia cells

  2020cites this paper
• T-Cell Dynamics in Chronic Lymphocytic Leukemia under Different Treatment Modalities

  2020cites this paper
• Base Excision Repair in the Immune System: Small DNA Lesions With Big Consequences

  2020cites this paper
• IgCaller for reconstructing immunoglobulin gene rearrangements and oncogenic translocations from whole-genome sequencing in lymphoid neoplasms

  2020cites this paper
• Evaluation of Somatic Hypermutation Status in Chronic Lymphocytic Leukemia (CLL) in the Era of Next Generation Sequencing

  2020cites this paper
• Primary vitreoretinal lymphomas display a remarkably restricted immunoglobulin gene repertoire.

  2020cites this paper
• HLA allele repertoire in Russian chronic lymphocytic leukemia patients with an unfavorable prognosis

  2020cites this paper
• An Updated Perspective on Current Prognostic and Predictive Biomarkers in Chronic Lymphocytic Leukemia in the Context of Chemoimmunotherapy and Novel Targeted Therapy

  2020cites this paper
• Autoimmune hemolytic anemia in adults: primary risk factors and diagnostic procedures

  2020cites this paper
• B cell signalling pathways—New targets for precision medicine in chronic lymphocytic leukaemia

  2020cites this paper
• IGLV3-21*01 is an inherited risk factor for CLL through the acquisition of a single-point mutation enabling autonomous BCR signaling

  2020cites this paper
• A stereotyped light chain may shape virus-specific B-cell receptors in HCV-dependent lymphoproliferative disorders

  2020cites this paper
• Molecular profiling of immunoglobulin heavy-chain gene rearrangements unveils new potential prognostic markers for multiple myeloma patients

  2020cites this paper
• B Cell Receptor Immunogenetics in B Cell Lymphomas: Immunoglobulin Genes as Key to Ontogeny and Clinical Decision Making

  2020cites this paper
• Going Rogue: how autoantibodies become pathogenic.

  2020cites this paper
• Autoimmune Cytopenias in Chronic Lymphocytic Leukemia: Focus on Molecular Aspects

  2020cites this paper
• Additional B-cell malignancies in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL)

  2020cites this paper
• Pathogenesis of chronic lymphocytic leukemia and the development of novel therapeutic strategies

  2020cites this paper
• Репертуар HLA-аллелей у российских больных хроническим лимфолейкозом с неблагоприятным прогнозом

  2020cites this paper
• IGLV3-21R110 identifies an aggressive biological subtype of chronic lymphocytic leukemia with intermediate epigenetics.

  2020cites this paper
• Exploiting B-cell Receptor Stereotypy to Design Tailored Immunotherapy in Chronic Lymphocytic Leukemia

  2020cites this paper
• Role of Specific B-Cell Receptor Antigens in Lymphomagenesis

  2020cites this paper
• Higher-order connections between stereotyped subsets: implications for improved patient classification in CLL.

  2020cites this paper
• Microenvironment Remodeling and Subsequent Clinical Implications in Diffuse Large B-Cell Histologic Variant of Richter Syndrome

  2020cites this paper
• Reading the B cell receptor Immunome in Chronic Lymphocytic Leukemia: Revelations and Applications.

  2020cites this paper
• Immunoglobulins or Antibodies: IMGT® Bridging Genes, Structures and Functions

  2020cites this paper